ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Jakavi 5 mg/ml, Lösung zum Einnehmen - 60 ml
69722001 Novartis Pharma Schweiz AG
Jakavi 5 mg/ml, Lösung zum Einnehmen27.03.2025
  27.03.2025
Ruxolitinib (L01EJ01) 
WHO-DDD26.03.2030
60 ml
07.16.10. 
A  
No 
  
PR  
k.A.PR
  
7680697220016Synthetika
  
Composition
ruxolitinibum 5 mg ut ruxolitinibi phosphas, propylenglycolum 150.0 mg, E 218 1.2 mg, propylis parahydroxybenzoas 0.4 mg, sucralosum, acidum citricum, aromatica (Erdbeer), aqua purificata, ad solutionem pro 1 ml.
Packungsbestandteile
Solution (oral)
 
 
Active AgentDose
Ruxolitinibum5 mg/ml
 
Inactive agentsDoseadditional_information
Citric Acid  
Aqua Purificata  
Aromatica (Erdbeer)  
E 2181.2 mg/mlconserv.
Propylenglycol150 mg/ml 
Propylis Parahydroxybenzoas0.4 mg/ml 
Sucralosum  
Source
Data was imported : 04.04.2025 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home